Victorian-style gallery blocks with a warden’s desk at one end have been abandoned in favour of a staff station placed more centrally, in a way that encourages interaction rather than observation.. Main, central functions like dining, exercise equipment and access to medical care have been broken up and placed in each house block.

Available to purchase at.'Transforming Small Molecule API Manufacturing' explores the innovative strides being made towards more efficient, sustainable, and cost-effective drug production.. Adrian La Porta.shares his insights on the pivotal role of miniaturisation and automation in shaping the future of Active Pharmaceutical Ingredients (APIs) production, highlighting the potential for significant industry transformation.. Watch now for a unique perspective on how modern advancements are paving the way for a new era in pharmaceuticals, not only redefining manufacturing processes but also promising a healthier future for all.Presented by our Head of Sustainability, Helen Hough, this video takes you on a journey through the development of The Forge, a landmark London project that represents a significant leap in sustainable construction..

Discover the pioneering use of a platforms approach to Design for Manufacture and Assembly (P-DfMA) and how it contributed to a remarkable reduction in whole-life carbon emissions..Through Helen's expert insights, learn about the collaborative efforts and innovative strategies that make The Forge a model for future construction projects aiming for environmental excellence.Through this 'In Short' episode,.delves into the challenges and breakthroughs in pharmaceutical manufacturing, exploring how new approaches like process intensification, automation, and continuous processing can lead to more agile, cost-effective, and environmentally friendly production methods.. Click the 'play button' above to listen in, or read our 5 Key Takeaways from this episode below.... 1.

Revolution in small molecule API production:.The episode highlights the transformative research and development in small molecule Active Pharmaceutical Ingredients, emphasising the generation of new, more complex, and targeted molecules.

This revolution is pivotal for advancing the mainstay of essential medicines globally.. 2.

Challenges in traditional manufacturing:.It’s really about individual value drivers and these vary from client to client depending on their needs.. “Construction too easily gets into the solutions mode,” he says, “and starts thinking of the solution before answering the question.”.

Amy Marks says she worked with a technology client earlier in her career, who wasn’t at all interested in having his project finish sooner.However, certainty surrounding the duration of the schedule was very important to him..

This is a value-driver that is well known to Johnston, as a result of Bryden Wood’s work within the.pharmaceutical industry.